Drew Watson

Dr. Drew Watson, Ph.D served as Senior Vice President of Biostatistics of Genomic Health Inc. since 2003. In this position, Dr. Watson and his team provide oversight of biostatistical, informatics, data management and medical operations activities related to the design, analysis, regulatory submission and commercialization of Genomic Health’s Oncotype DX tests. Dr. Watson served as Chief Executive Officer of Novation Biosciences, Inc. and founded it. Dr. Watson has more than 20 years of experience in applied statistics, informatics, and business management. From 1997 to 2001, Dr. Watson served in various roles at Incyte Genomics, Inc. He was previously an executive at Incyte Genomics where he held positions as Vice President of Biostatistics and Quantitative Biology and General Manager of Incyte Microarray Systems. Prior to Incyte, Dr. Watson held management positions at Chiron Corporation and Syntex Pharmaceuticals. He also co-founded a management consulting firm, Process Plus Inc., whose client list included Hewlett-Packard, Intel, Applied Materials, Dow Chemical and NEC. Additionally, he is an inventor of a number of key patents related to genomics, algorithm development, and molecular diagnostics. Dr. Watson obtained his B.Sc. in Statistics from California State University, Hayward, an M.S. in Mathematical and Computational Statistics from Stanford University, a Ph.D. in Biostatistics from University of California, Los Angeles, an MBA from Golden Gate University and trained with Dr. W. Edwards Deming - the world-renowned statistician and management consultant.